chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Broke out all over with rash started with underarms then moved/broke out in a mid rash but it was head to toe; Itching; Arm soreness; Fatigue; Mild fever; Achiness; This is a spontaneous report received from a contactable consumer reported for herself. A 56-year-old female patient (non-pregnant) received first dose bnt162b2 (Bnt162b2, Solution for injection, Lot number: EN6207, Expiration date was not reported) via unspecified route of administration in left arm on 18Mar2021 at 3:45 PM at first dose single for covid-19 immunisation. The patient relevant medical history included Hashimoto thyroid disorder. The patient has allergy to amoxicillin or benzonatate and broke out with hives while taking both. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines 4 weeks prior to administration of COVID vaccine. Concomitant medications included levothyroxine sodium (SYNTHROID), spironolactone, calcium and ergocalciferol (VIT D) and Krill. Since the vaccination, the patient has not been tested for COVID-19. On 19Mar2021, the very next day after vaccination, the patient experienced fatigue, mild fever, arm soreness, achiness and then the next day was fine. Then a week later on 25Mar2021 13:15 she broke out in a mild rash, she literally started breaking out on the inside of her arms, it went from head to toe and moved all over body. The itchiness lasted for 4 days but was better each day. She said the rash/itchiness is similar when she had an allergic reaction to amoxicillin. The patient was confused about taking the second dose of vaccination due to reaction after first dose. She spoke to her doctor about it, and he suggested not to take the second dose of the vaccine but her son's pediatrician suggested to contact Pfizer for the same. The events rash all over and itchiness were considered as medically significant. Patient received the treatment of Claritin for the adverse events of Itching and rash all over. The outcome of the events fatigue, mild fever, arm soreness and achiness were recovered on 20Mar2021, Itching was recovered on 29Mar2021 and rash all over was recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
pt recvd vax; had hives, dry skin, joints swelled, c/o pain, crying; taken to er; still has hives, c/o joints aching;
Janssen COVID-19 Vaccine EUA Mild case of hives begun around 54 hours after receiving vaccine shot; will take Benadryl.
Pain, redness, swelling at injection site starting about 5 hours post injection.  Fever >100.5 °, shivering, starting around 10 hours post injection, during sleep.  Treated with Tylenol and Advil upon waking.
Dizziness upon rising and getting back into bed. Dizziness upon changing the state of balance such as standing after being seated. No treatment.
Fatigue; Nauseous; Red rash again on my arm, itched; Red rash again on my arm; red rash again on my arm it swelled up; Chills; Sore arm; Fever; Headache; Flu-like side symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like side symptoms), VACCINATION SITE PRURITUS (Red rash again on my arm, itched), VACCINATION SITE RASH (Red rash again on my arm), VACCINATION SITE PAIN (Sore arm) and VACCINATION SITE SWELLING (red rash again on my arm it swelled up) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008821A and 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Food allergy (HONEY,NUTTIN), Pollen allergy and Fibromyalgia. Concomitant products included ATENOLOL for Blood pressure management, CHLORPHENIRAMINE MALEATE from an unknown date to 10-Mar-2021 for Pollen allergy, LEVETIRACETAM for Spasticity and Fibromyalgia.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like side symptoms), VACCINATION SITE PAIN (Sore arm), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever). On 10-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Red rash again on my arm, itched), VACCINATION SITE RASH (Red rash again on my arm) and VACCINATION SITE SWELLING (red rash again on my arm it swelled up). On 14-Apr-2021, the patient experienced NAUSEA (Nauseous). On an unknown date, the patient experienced FATIGUE (Fatigue). On 10-Apr-2021, PYREXIA (Fever) had resolved. On 17-Apr-2021, INFLUENZA LIKE ILLNESS (Flu-like side symptoms), VACCINATION SITE PRURITUS (Red rash again on my arm, itched), VACCINATION SITE RASH (Red rash again on my arm), VACCINATION SITE PAIN (Sore arm), CHILLS (Chills) and HEADACHE (Headache) had resolved. At the time of the report, VACCINATION SITE SWELLING (red rash again on my arm it swelled up) had not resolved and FATIGUE (Fatigue) and NAUSEA (Nauseous) outcome was unknown.            No treatment information was provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-050374 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 18-Apr-2021: Updated some of the event details. On 16-May-2021: Current condition and ADR form updated. On 29-Jul-2021: Follow-up added information for first dose of vaccine, updated batch number for second dose of vaccine, concomitant medications, outcome updated for events of sore arm, rash, headache, chills itch and flu symptoms to recovered.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-050374:First dose case
She got her 3rd oral dose of Typhoid in a serious of 4, had dizziness, extreme dizziness and ended up collapsing on the floor and lasted for 24 hours, and moving her head the slightest bit would cause nausea.  She had to lie down and do nothing for that 24 hours, could not sleep due to the dizziness.  Eventually it eased up.  She took the last dose of the vaccine on Sunday afternoon, and the dizziness is coming back which she does not know if it's related to the vaccine or something else is going on.  She did not take anything for her dizziness.  Saturday night they tried calling the hospital and told that they did not give advice and did not have insurance so they decided to do nothing and did not contact anybody.  She was improved yesterday, but today is still very woozy and does not feel confident in driving a car as she does not feel it would be safe.
Numbness in arms and face every day since 8 pm on April 08, 2021.  More prevalent in the afternoon.  I went to my Doctor on April 23, 2021, at 8:40 am for my regular check-up and I did inform them that I was having this reaction and I got no response.
patient received a vaccine that had been stored improperly during a temperature excursion; This spontaneous report was received from a medical assistant referring to a 12 months old  patient of unknown gender. The patient's concurrent conditions, pertinent medical history, concomitant medications, drug reactions/allergies were not reported.    On 07-AUG-2020, the patient received improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot #: S028919, expiration date: 16-SEP-2021) 0.5 milliliter (strength and route of administration were not provided) as prophylaxis (product storage error). The vaccine was exposed to temperature of 6 to 14 degrees Fahrenheit (8 degrees Fahrenheit) for 2 minutes and 30 seconds. No previous excursions was reported. The data logger was involved. No additional adverse events were reported.
This spontaneous report was received from licensed practical nurse and refers to a 14 or 15 year-old female patient (currently 20 years old) via a company representative. The patient's concurrent conditions and medical history were not reported. On approximately 28-MAY-2010 (reported as "about 5 or 6 years ago"), the patient was vaccinated with her third dose of GARDASIL intramuscularly injection (concentration, dose, anatomical place of vaccination, lot # and expiration date were not provided). Information regarding concomitant therapies was not reported. On approximately May 2010 (reported as "following the third dose of GARDASIL"), the patient experienced warts on her feet (skin papilloma). Therefore, she was sent to a podiatrist and her warts were burned off on an unspecified date. At the time of reporting, the patient recovered from the skin papilloma and the reporter stated that it was determined that the skin papilloma was related to GARDASIL. Additional information has been requested.
Case number PHHY2011US85588 is an initial literature report received on 04 Sep 2011. The authors present a case of transverse myelitis in a neonate. This case refers to a six month old neonate of unknown gender (table 3). This healthy neonate was vaccinated with Hib (manufacturer and batch number: unknown, therefore conservatively taken as VAXEMHIB INN), DTaP (other manufacturer) and PCV-7 (manufacture and batch number: unknown) on an undetermined date. Fourteen days after vaccination, this neonate experienced transverse myelitis. The causality was assessed as possible by the reporter. No further information about the outcome of the event was available.
numb, burning hands and feet, Joint pain, metallic taste, burning tongue, burning scalp  I am still struggling with joint pain and burning tongue very severely- all my tests are normal and negative ->  I need help very frustrating. I can't function
2:30 pm - vaccine, 10:00 pm - fever/chills, 01/05/2018 - fever broke, 01/05/2018 - achy exhausted for the rest of the day, 01/06/2018 - still achy 1:00 pm started itching and continued until 01/08/2018, 01/09/2018 - itching stopped.
Shortness of breathe, headache, severe body aches, rash on neck and chest, low grade fever.
really tired; This is a spontaneous report from a contactable consumer (patient's sister). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number unknown), via an unspecified route of administration on 08Jan2021 at a single dose for COVID-19 immunization. The patient's medical history included parkinsons. Concomitant medications were not reported. The patient was having a hard time right now. He was really tired on Jan2021 and does not know if he has any other symptoms. Outcome of the event was unknown.
Dizziness, Everything went black, all color went from lips, unconsciousness. Returned to public health office where she was given the vaccine she was placed on a medical table and told to lay down with an ice pack behind her neck for about 20 minutes. I am filling out this report on Sunday 09/05/10 and her arm is still very hard and sore in the injection spot also, has had diarrhea, upset stomach and headaches.
T-100.5.  11.5x13.5cm rounded, raised, pink & warm area.  Smaller 4x5cm bruised area on side reaction area.  Hive like reaction below reaction yesterday.
Patient diagnosed with Idiopathic Thrombocytopenic purpura (blood platelet disorder) 11/8 Blood platelet count to 500. Started treatment with WinRho 10/19 clear of disorder by hematologist at hospital. Since vaccine diagnosed with following food allergies: soy, milk, egg whites, and wheat.
I had a fever the second night after getting the second vaccine shot. I felt very very weak and my menstrual cycle is very irregular. I was bleedy heavily for the. next 3 days where I had to change every half hour. It was very bad. I went to the ER on the 3rd or 4th day.
phone call 1 hr p/vax, hives & blisters on back of arms, tight chest; sent to ER immed; denies any allergies; denies allergy to yeast;
Arm started to itch, then turned bright red with a lot of heat radiating from around injection site. Then a knot formed and the itching  started to radiate down to elbow from injection site. This occurred in about 15-20 minutes after injection was given. Arm is still sore to touch and radiating heat 2 days later. Also feeling extremely fatigued.
The patient called the pharmacy 3/12/19 and said she had a fever above 100 degrees (she could not tell me the exact temp), chills, and a rash on her breasts and stomach. She said she took TYLENOL for the fever and it was worse for the first 2 days. I told her to monitor symptoms and try BENADRYL for the rash, and to call her PCP if there is any worsening of the reaction.
This spontaneous report as received from a physician refers to 2 patients of unknown age. The patients were vaccinated subcutaneously with a 0.65 ml single dose of ZOSTAVAX (lot # not reported) on an unspecified date. No other co-suspects were reported. No concomitant medications were reported. The physician reported that on an unknown date the patient developed shingles subsequent to receiving their vaccination. No treatment information was reported. Both patients improved and the outcome of shingles was reported as recovered. The relatedness for the event was not provided for ZOSTAVAX. Additional information is not expected.
Information has been received from a pharmacist concerning a 76 year old female who was vaccinated with, 0.65 ml ZOSTAVAX (reported Lot# H011049; exp. 05-SEP-2013) on 19-SEP-2012. The pharmacist reported that the patient came down with shingles rash. The patient noticed red rash on her left hip on 26-SEP-2012. The pharmacist reported that the rash started dying up without any treatment. Additional information requested.
Information has been received from a woman concerning an 11 year old white female with no allergies or medical history who on 11-SEP-1997 was vaccinated SC with a first dose of Varivax. There were no concomitant vaccines. There was no illness at the time of vaccination. On 24-SEP-2006, at 15:00, the patient developed red sites on her lower abdomen. The next day, on 25-SEP-2006, she had one to two on her left arm. On approximately 26-SEP-2006, she had one on her face. She had a total of 15- to 20 sites that were red with itching. She also had symptoms of an upper respiratory infection. No diagnostic laboratory tests were performed. She recovered on 02-OCT_2006. She had no adverse events following prior vaccination. Additional information is not expected.
This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. Information about concomitant medication, pertinent medical history and drug reactions/allergies was not provided. On 14-NOV-2018, the patient was vaccinated with improperly stored ROTATEQ (lot # R015432, expiration date 15-APR-2020) for prophylaxis (strength, dose detail, anatomical location and route of administration were not reported). No adverse effect was reported. The vaccine was exposed to temperature excursion between 0 degree Celsius (C) and 1 degree C for a time frame of 19 minutes and between 9 degree C and 25 degree C for 1 hour without previous temperature excursion. Data logger was involved. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1901USA001125:
Patient received Influenza vaccine QUADRIVALENT 10/18/2016. On 10/20/2016 the patients mother contacted the clinic where the patient received the injection stating that at the injection site there was a "golf ball sized" red, hot hardened area, at the injection site.
29JAN98 vesicular rash devel all over body;febrile off & on for 3 days;sore throat-pox in the mouth;pt was unwell for 7 days + lt eye;
unconsolable crying for 6 hrs p/immun; had given APAP prior to immun; pt didn't want to be touched or diaper changed would cry more intensely if touched; didn't mention problems w/vax;
Patient received second dose of Moderna COVID19 vaccine at another facility and was seen via televisit by our office on 01/27/2021 for complaints of moderate joint pain, intolerance to external temperatures, rash covering body from head to knees.
ADMINISTRATION OF EXPIRED VACCINE; This spontaneous report received from a health care professional concerned a 52 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808982, expiry: 21-SEP-2021) dose was not reported, administered on 24-SEP-2021 for prophylactic vaccination. No concomitant medications were reported.  On 24-SEP-2021, the patient experienced administration of expired vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of expired vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20210952956.
Flu like aches; pain; several were in bed 2-3days/ more severe on second dose (1-2 days in bed); Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (several were in bed 2-3days/ more severe on second dose (1-2 days in bed)), INFLUENZA LIKE ILLNESS (Flu like aches) and PAIN (pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (several were in bed 2-3days/ more severe on second dose (1-2 days in bed)), INFLUENZA LIKE ILLNESS (Flu like aches) and PAIN (pain). At the time of the report, VACCINATION COMPLICATION (several were in bed 2-3days/ more severe on second dose (1-2 days in bed)), INFLUENZA LIKE ILLNESS (Flu like aches) and PAIN (pain) outcome was unknown. Not Provided          No concomitant medication was provided No treatment medication was provided   This case was linked to MOD-2021-256791 (Patient Link).
Information has been received from the authors in a published literature article regarding a 19 month old patient of unknown gender. The patient's concurrent conditions and pertinent medical history were not reported. On an unknown date, in approximately September 2013, when the patient was 12 months old, the patient was vaccinated with 1 dose of MMR (Manufacturer unknown), (Lot #, exp date, strength and dose were not provided). There was no concomitant medication reported. On 17-APR-2014, the child was febrile and developed a rash while on an international flight. The child's illness was clinically compatible with measles, which was confirmed by polymerase chain reaction and immunoglobulin M serology, on an unknown date in April 2014. The case was genotyped as D8 (endemic where the child evidently acquired measles). The child was admitted for 3 days at the hospital and was fully recovered without complications, on an unknown date in April 2014. Although primary vaccine failure was not laboratory confirmed in this case, the child's highly elevated acute immunoglobulin M serology result and classic clinical presentation were consistent with immunologic naivete before infection, on an unknown date. The outcome of vaccine failure was not reported. The reporter authors considered vaccination failure and measles to be related to MMR (Manufacturer unknown). Additional information has been requested.
Diarrhea, First generalized fatigue, arm pain, diarrhea Narrative:
increasing pain in his head; This case was reported by a physician and described the occurrence of headache in a 53-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included shingles (a possible h/o atypical facial zoster on the left), pain (with not much prodomal pain) and pustular rash (pustular rash).   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced headache. On an unknown date, the outcome of the headache was unknown.   It was unknown if the reporter considered the headache to be related to Shingrix and Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. On an unknown dats patient received 2 doses of shingrix vaccine and experienced increasing pain in his head that was not restricted to the left side where the rash was present. The lot number and injection site was not known. The reporter consented to follow up.
J&J Covid Vaccine received 9/16 @ 2:35pm. Heavy waves nausea & dizziness began within 5 min and through night. 9/17 - extreme leg pains, difficulty walking, dizziness, intense headaches  9/18 - random bouts of dizziness, general fatigue. 9/19 - chest pains & tightness in neck periodically through day, sporadic dizziness (to the point of near fainting a couple times) 9/20 - lighter chest pains & some tightness in neck periodically through day. 9/21 - sporadic lighter chest tightness, but still feeling tightness in neck periodically followed by intense tingling on the top of my head while walking for exercise. 9/22 through 9/25 - most symptoms seem to have eased up over a few days, but still have sporadic moments of dizziness, chest pains, and neck tightness. Note: doctor prescribed continuous Balziva (birth control pill) - no breaks for periods for multiple months. Stopped taking 9/19 for fear of complications with vaccine especially after extreme leg pains and chest pains. Waited to submit this report until 4 weeks out in hopes that I am mostly out of the window of developing the blood clot disorder, but will submit an additional report should anything else develop as I know most issues with vaccines happen within 42 days which would be another couple weeks from now.
Pain in the lower pelvic area; Fatigue; Pain on right arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain on right arm), PELVIC PAIN (Pain in the lower pelvic area) and FATIGUE (Fatigue) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     Concurrent medical conditions included Lymph node disorder.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain on right arm) and FATIGUE (Fatigue). On 17-Mar-2021, the patient experienced PELVIC PAIN (Pain in the lower pelvic area). On 13-Mar-2021, PAIN IN EXTREMITY (Pain on right arm) and FATIGUE (Fatigue) had resolved. At the time of the report, PELVIC PAIN (Pain in the lower pelvic area) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable. Concomitant product use was not provided by the reporter.  No treatment information were reported. .
SORE ARM; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On 2021, the subject experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm on 2021. This report was non-serious.